SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-284279
Filing Date
2011-10-27
Accepted
2011-10-27 16:49:01
Documents
10
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d239260d10q.htm 10-Q 579483
2 SECTION 302 CEO CERTIFICATION d239260dex311.htm EX-31.1 9748
3 SECTION 302 CFO CERTIFICATION d239260dex312.htm EX-31.2 9600
4 SECTION 906 CEO CERTIFICATION d239260dex321.htm EX-32.1 2930
5 SECTION 906 CFO CERTIFICATION d239260dex322.htm EX-32.2 2919
  Complete submission text file 0001193125-11-284279.txt   2058129

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT qcor-20110930.xml EX-101.INS 288586
7 XBRL TAXONOMY EXTENSION SCHEMA qcor-20110930.xsd EX-101.SCH 6004
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE qcor-20110930_cal.xml EX-101.CAL 36151
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE qcor-20110930_lab.xml EX-101.LAB 97685
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qcor-20110930_pre.xml EX-101.PRE 64399
Mailing Address 1300 NORTH KELLOGG DRIVE SUITE D ANAHEIM CA 92807
Business Address 1300 NORTH KELLOGG DRIVE SUITE D ANAHEIM CA 92807 714-786-4200
QUESTCOR PHARMACEUTICALS INC (Filer) CIK: 0000891288 (see all company filings)

IRS No.: 330476164 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14758 | Film No.: 111162468
SIC: 2834 Pharmaceutical Preparations